Everest Medicines, a Chinese innovative biopharmaceutical company incubated by CBC Group, announced that it has successfully completed US$310 million in Series C financing. It is one of the largest financing rounds completed by unlisted companies in the Chinese healthcare sector since the epidemic. This round involves many reputable domestic and foreign investors such as Janchor […]
CBC Group-incubated Everest Medicines Completes $310M Series C Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.